% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Schifflers:274204,
author = {C. Schifflers$^*$ and S. Zottnick$^*$ and J. Förster$^*$
and S. Kruse$^*$ and R. Yang$^*$ and H. Wiethoff$^*$ and M.
Bozza$^*$ and K. Hoppe-Seyler$^*$ and M. Heikenwälder$^*$
and R. P. Harbottle$^*$ and C. Michiels and A. Riemer$^*$},
title = {{D}evelopment of an {O}rthotopic {HPV}16-{D}ependent {B}ase
of {T}ongue {T}umor {M}odel in {MHC}-{H}umanized {M}ice.},
journal = {Pathogens},
volume = {12},
number = {2},
issn = {2076-0817},
address = {Basel},
publisher = {MDPI},
reportid = {DKFZ-2023-00490},
pages = {188},
year = {2023},
note = {#EA:F130#LA:F130#},
abstract = {Head and neck squamous cell carcinomas (HNSCC) caused by
infections with high-risk human papillomaviruses (HPV) are
responsible for an increasing number of head and neck
cancers, particularly in the oropharynx. Despite the
significant biological differences between HPV-driven and
HPV-negative HNSCC, treatment strategies are similar and not
HPV targeted. HPV-driven HNSCC are known to be more
sensitive to treatment, particularly to radiotherapy, which
is at least partially due to HPV-induced immunogenicity. The
development of novel therapeutic strategies that are
specific for HPV-driven cancers requires tumor models that
reflect as closely as possible the characteristics and
complexity of human tumors and their response to treatment.
Current HPV-positive cancer models lack one or more
hallmarks of their human counterpart. This study presents
the development of a new HPV16 oncoprotein-dependent tumor
model in MHC-humanized mice, modeling the major biologic
features of HPV-driven tumors and presenting
HLA-A2-restricted HPV16 epitopes. Furthermore, this model
was developed to be orthotopic (base of tongue). Thus, it
also reflects the correct tumor microenvironment of
HPV-driven HNSCC. The cancer cells are implanted in a manner
that allows the exact control of the anatomical location of
the developing tumor, thereby homogenizing tumor growth. In
conclusion, the new model is suited to study HPV16-specific
therapeutic vaccinations and other immunotherapies, as well
as tumor-targeted interventions, such as surgery or
radiotherapy, or a combination of all these modalities.},
keywords = {head and neck squamous cell carcinoma (Other) / human
papillomavirus (Other) / orthotopic tumor model (Other)},
cin = {F130 / F030 / F190 / F160 / F065 / F180},
ddc = {610},
cid = {I:(DE-He78)F130-20160331 / I:(DE-He78)F030-20160331 /
I:(DE-He78)F190-20160331 / I:(DE-He78)F160-20160331 /
I:(DE-He78)F065-20160331 / I:(DE-He78)F180-20160331},
pnm = {316 - Infektionen, Entzündung und Krebs (POF4-316)},
pid = {G:(DE-HGF)POF4-316},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36839460},
pmc = {pmc:PMC9958775},
doi = {10.3390/pathogens12020188},
url = {https://inrepo02.dkfz.de/record/274204},
}